Depletion of Beta Cell Intranuclear Rodlets in Human Type II Diabetes
Affiliations
Affiliations
- Department of Pathology, Case Western Reserve University, Cleveland, OH, USA.
- Department of Pathology, Stanford University, 300 Pasteur Drive, Palo Alto, CA, USA.
- Department of Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada.
- Department of Surgery, Jaber Al-Ahmed Armed Forces Hospital, Kuwait City, Kuwait.
- Department of Biochemistry, The Ottawa Hospital Research Institute, Microbiology and Immunology, University of Ottawa, Ottawa, Canada.
- Department of Pathology and Laboratory Medicine, Ottawa Hospital Research Institute, Centre for Neurosciences, University of Ottawa, Ottawa, Canada. jwoulfe@toh.ca.
Abstract
Intranuclear rodlets (INRs) are rod-shaped intranuclear bodies of unknown function present in the nuclei of pancreatic beta cells. Previous studies have demonstrated a significant depletion of INRs from beta cells in mouse models of type II diabetes, suggesting that they may have pathological significance. The objective of the present study was to determine whether beta cell INRs show quantitative alterations in human type II diabetes. In sections of non-neoplastic pancreas from 23 diabetic patients and 23 controls who had undergone complete or partial pancreatectomy, we detected a significant reduction in the proportion of INRs in insulin-immunoreactive beta cells. In addition, we showed that beta cell INRs are immunoreactive for the RNA-binding protein HuR. The results of this study confirm and extend our previous study and implicate this enigmatic nuclear structure in the cellular pathophysiological mechanisms underlying the development of type II diabetes in humans.
Keywords: Beta cells; Diabetes; HuR; Insulin; Intranuclear rodlets.
Similar articles
Depletion of intranuclear rodlets in mouse models of diabetes.
Milman P, Fu A, Screaton RA, Woulfe JM.Endocr Pathol. 2010 Dec;21(4):230-5. doi: 10.1007/s12022-010-9136-5.PMID: 20922502
Intranuclear rodlets in human pancreatic islet cells.
Prichett W, Milman P, Gagnon J, Munoz DG, Woulfe J.Pancreas. 2007 Oct;35(3):207-11. doi: 10.1097/MPA.0b013e318067fee1.PMID: 17895839
Promyelocytic leukaemia-immunoreactive neuronal intranuclear rodlets in the human brain.
Woulfe JM, Prichett-Pejic W, Rippstein P, Munoz DG.Neuropathol Appl Neurobiol. 2007 Feb;33(1):56-66. doi: 10.1111/j.1365-2990.2006.00789.x.PMID: 17239008
Protection of pancreatic beta-cells: is it feasible?
Bonora E.Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004.PMID: 18096375 Review.
Van Gassen N, Staels W, Van Overmeire E, De Groef S, Sojoodi M, Heremans Y, Leuckx G, Van de Casteele M, Van Ginderachter JA, Heimberg H, De Leu N.Stem Cells Transl Med. 2015 Jun;4(6):555-63. doi: 10.5966/sctm.2014-0272. Epub 2015 Apr 6.PMID: 25848123 Free PMC article. Review.
Cited by
Nuclear IMPDH Filaments in Human Gliomas.
Ahangari N, Munoz DG, Coulombe J, Gray DA, Engle EC, Cheng L, Woulfe J.J Neuropathol Exp Neurol. 2021 Oct 26;80(10):944-954. doi: 10.1093/jnen/nlab090.PMID: 34498062 Free PMC article.
KMEL References
References
-
- J Biol Chem. 2017 Feb 24;292(8):3466-3480 - PubMed
-
- Bioessays. 2011 Aug;33(8):582-7 - PubMed
-
- Curr Top Med Chem. 2017;17 (12 ):1331-1335 - PubMed
-
- Brain Pathol. 2002 Jul;12(3):300-7 - PubMed
-
- Endocrinology. 1984 Sep;115(3):1125-34 - PubMed
-
- Endocr Rev. 2007 Apr;28(2):187-218 - PubMed
-
- Diabetologia. 2017 Aug;60(8):1363-1369 - PubMed
-
- Igaku To Seibutsugaku. 1969 May 10;78(5):193-6 - PubMed
-
- Pancreas. 2007 Oct;35(3):207-11 - PubMed
-
- Cell Death Differ. 2015 May;22(5):703-18 - PubMed
-
- Genome Res. 2010 Jun;20(6):722-32 - PubMed
-
- J Cell Biol. 1969 Nov;43(2):377-81 - PubMed
-
- Mol Cancer. 2003 Jan 06;2:4 - PubMed
-
- Endocr Rev. 2007 Oct;28(6):653-63 - PubMed
-
- Neuropathol Appl Neurobiol. 2000 Apr;26(2):161-71 - PubMed
-
- Endocr Pathol. 2010 Dec;21(4):230-5 - PubMed